Subtitle
Proton therapy for central nervous system tumors in children.
Subtitle
Proton therapy for central nervous system tumors in children.
Proto therapy Time
April 2018
Executive summary
A systematic review conducted by John Hopkin and MGH. It highlighted the capability of protons to decrease radiation exposure for children is regarded as an important advance in pediatric cancer care, particularly for central nervous system (CNS) tumors.
Favorable clinical outcomes have been reported and justify the increased cost and burden of this therapy.
Top cancer treatments
Related contents
Proton Therapy Publication
November 2024
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial.
Proton Therapy Publication
September 2024
Proton therapy for adult-type diffuse glioma: A systematic review.
Proton Therapy Publication
October 2024
Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas.
Proton Therapy Publication
October 2024
Patient reported fatigue after proton therapy for malignant brain tumours - Is there a relation between radiation dose and brain structures?
Proton Therapy Publication
September 2024
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma.
Proton Therapy Publication
May 2024
Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
Proton Therapy Publication
May 2024
Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.
Proton Therapy Publication
June 2024
Possible association of dose rate and the development of late visual toxicity for patients with intracranial tumours treated with pencil beam scanned proton therapy.
Proton Therapy Publication
August 2024
Proton therapy for intracranial meningioma: a single-institution retrospective analysis of efficacy, survival and toxicity outcomes.